Literature DB >> 6252184

Pharmacokinetics of cefotaxime in normal human volunteers.

F Esmieu, J Guibert, H C Rosenkilde, I Ho, A Le Go.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252184     DOI： 10.1093/jac/6.suppl_a.83

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  31 in total

1.  Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.

Authors:  Charles Burdet; Nathalie Grall; Morgane Linard; Antoine Bridier-Nahmias; Michèle Benhayoun; Khadija Bourabha; Mélanie Magnan; Olivier Clermont; Camille d'Humières; Olivier Tenaillon; Erick Denamur; Laurent Massias; Sarah Tubiana; Loubna Alavoine; Antoine Andremont; France Mentré; Xavier Duval
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.

Authors:  Claire Dahyot-Fizelier; Denis Frasca; Nicolas Grégoire; Christophe Adier; Olivier Mimoz; Bertrand Debaene; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

3.  Third generation cephalosporins in the parenteral to oral switch.

Authors:  D Rimmer
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

4.  In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents.

Authors:  S Oie; K Hironaga; A Koshiro; H Konishi; Z Yoshii
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

5.  Cefotaxime concentrations in prostatic tissue.

Authors:  A Genov; B Riedel; C Savopoulos; K Seeger; G Seidel
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

6.  Prophylactic cephalosporin in prostatic surgery.

Authors:  S Selwyn
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

7.  Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.

Authors:  U Neubert; H C Korting; G Ruckdeschel
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.

Authors:  Elsa Maksoud; Berengere Koehl; Aude Facchin; Phuong Ha; Wei Zhao; Florentia Kaguelidou; Malika Benkerrou; Patricia Mariani; Albert Faye; Mathie Lorrot; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  Pharmacokinetics of ceftriaxone in liver-transplant recipients.

Authors:  A Toth; H Y Abdallah; R Venkataramanan; L Teperman; G Halsf; M Rabinovitch; G J Burckart; T E Starzl
Journal:  J Clin Pharmacol       Date:  1991-08       Impact factor: 3.126

10.  Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.

Authors:  J M Trang; R F Jacobs; G L Kearns; A L Brown; T G Wells; F L Underwood; R B Kluza
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.